Summary & Overview
CPT 11721: Debridement of Six or More Nails
CPT code 11721 represents the debridement of six or more nails, a procedure frequently performed by podiatrists and other physicians to address various nail disorders. This code is significant in medical billing and reimbursement, as it distinguishes more extensive nail debridement from procedures involving fewer nails. Nationally, the code is recognized by major payers including Aetna, Blue Cross Blue Shield, Cigna Health, Medicare, and UnitedHealthcare, ensuring broad coverage for patients requiring this service.
The publication provides a comprehensive overview of 11721, including payer coverage, clinical context, and related billing codes. Readers will gain insight into the procedural details, typical site of service, and how this code fits within the broader landscape of podiatric and surgical nail care. The analysis also highlights associated modifiers and taxonomies, as well as relevant ICD-10 diagnoses commonly linked to nail debridement. Additionally, comparisons to related CPT codes are included to clarify distinctions in coding for nail and skin procedures.
This summary serves as a resource for understanding the national policy environment, clinical benchmarks, and billing practices surrounding CPT code 11721.
CPT Code Overview
CPT code 11721 is used to report the debridement of six or more nails, which includes the partial or complete removal of nail(s) by any method. This procedure is commonly performed in the field of podiatry and is classified under surgical procedures on the nails. The typical site of service for this procedure is the office setting (Place of Service 11).
Clinical & Coding Specifications
Clinical Context
A patient presents to a podiatry office with multiple nail disorders affecting six or more toenails or fingernails. Common conditions include ingrowing nails, fungal infections (tinea unguium), onycholysis, onychogryphosis, or nail dystrophy. The patient may experience pain, difficulty walking, or cosmetic concerns. After evaluation, the provider determines that debridement of six or more nails is medically necessary. The procedure involves partial or complete removal of affected nails by any method, performed in an office setting. Documentation includes the number of nails treated, clinical findings, and relevant diagnoses.
Coding Specifications
-
Modifiers:
Modifier Code Description Usage Criteria Q7ONE CLASS A FINDING Used when one Class A finding is present, indicating severe pathology such as ulceration or gangrene. Q8TWO CLASS B FINDINGS Used when two Class B findings are present, such as absence of pulses or claudication. Q9ONE CLASS B AND TWO CLASS C FINDINGS Used when one Class B and two Class C findings are documented, indicating moderate risk factors. -
Provider Taxonomies:
213E00000X— Podiatrist207Q00000X— Family Medicine Physician207R00000X— Internal Medicine Physician
These specialties are eligible to perform and bill for nail debridement procedures.
Related Diagnoses
-
L60.0— Ingrowing nail- Indicates a nail growing into the surrounding skin, often causing pain and infection. Debridement is performed to relieve symptoms and prevent complications.
-
B35.1— Tinea unguium- Represents fungal infection of the nail (onychomycosis). Debridement helps remove infected nail material and improve treatment outcomes.
-
L60.1— Onycholysis- Describes separation of the nail from the nail bed. Debridement is used to remove loose or damaged nail tissue.
-
L60.2— Onychogryphosis- Refers to thickened, curved, or deformed nails. Debridement is necessary to reduce nail thickness and improve function.
-
L60.3— Nail dystrophy- Encompasses abnormal nail growth or structure. Debridement addresses cosmetic and functional issues associated with dystrophic nails.
Each diagnosis is clinically relevant as it represents a condition for which nail debridement may be indicated.
Related CPT Codes
-
11720— Debridement of nail(s) by any method(s); 1 to 5- Used when debridement is performed on fewer than six nails. Often an alternative to
11721when the number of nails treated is less.
- Used when debridement is performed on fewer than six nails. Often an alternative to
-
11055— Paring or cutting of benign hyperkeratotic lesion- Used for removal of a single benign hyperkeratotic lesion, such as a callus or corn. May be performed in conjunction with nail debridement if both conditions are present.
-
11056— Paring or cutting of benign hyperkeratotic lesion; 2 to 4 lesions- Used when treating 2 to 4 benign hyperkeratotic lesions. Can be billed alongside nail procedures if medically necessary.
-
11057— Paring or cutting of benign hyperkeratotic lesion; more than 4 lesions- Used for removal of more than 4 benign hyperkeratotic lesions. May be performed in the same visit as nail debridement if indicated.
These codes are related by their focus on podiatric procedures and are commonly used as alternatives or adjuncts depending on the number and type of lesions treated.
National Reimbursement Benchmarks
National mean rates for CPT code 11721 show that Medicare's average reimbursement ($46.55) is slightly below the BUCA (Blue Cross Blue Shield, UnitedHealth Group, Cigna, Aetna) commercial average ($47.71). UnitedHealth Group stands out with the highest mean rate at $64.59, while Aetna is the lowest among commercial payers at $38.74.
Rate dispersion, measured by the difference between the 75th and 25th percentiles, varies significantly across payers. Medicare exhibits the tightest range ($4.00), indicating consistent rates nationwide. In contrast, UnitedHealth Group has the widest range ($36.67), reflecting substantial variability in commercial reimbursement. Cigna also shows a broad spread ($32.00), while Aetna and Blue Cross Blue Shield have moderate ranges ($17.50 and $22.00, respectively).
The table and chart below present a detailed breakdown of national benchmarks for each payer, including mean rates and percentile values.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.